MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0041706
Starcine Pharmaceutical Private Limited
Starcine Pharmaceutical Private Limited - pharma in Bangalore, Karnataka, India. Directors, charges & compliance details.
Revenue · FY 2025
₹31.17 Lakh
▲ 36% YoY
Net loss · FY 2025
₹3.03 Lakh
Net margin -9.7%
EBITDA · FY 2025
₹32,834
EBITDA margin 1.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Starcine Pharmaceutical Private Limited
Data last updated:
Starcine Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2020PTC141585.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nagendra Ramachndrappa and Manjunath Narayana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.17 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹3.03 Lakh (net margin -9.7%) and EBITDA of ₹32,834 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
Starcine Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0041706).
Company details
CIN U24290KA2020PTC141585
Registration Number 141585
Incorporation Date 27 November 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0041706
Key People
Nagendra Ramachndrappa Director Manjunath Narayana Director Cheegatagere Ganga Reddy Lakshmana Reddy Director Recognitions & Rankings of Starcine Pharmaceutical
Contact details
Starcine Pharmaceutical Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo 52 Cellar Shivasharada Complex Annapoorneshwari Complex Srigandhada Ka, Val, Bangalore, Karnataka, India – 560091
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Starcine Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Starcine Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Starcine Pharmaceutical Private Limited, buy the company report.
Financials of Starcine Pharmaceutical Private Limited
FY 2025 filings availableStarcine Pharmaceutical Private Limited reported revenue of ₹31.17 Lakh (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹31.17 Lakh ▲ 36%
Net loss · FY 2025
₹3.03 Lakh margin -9.7%
EBITDA · FY 2025
₹32,834 margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▼ 60%
Revenue has grown at a compounded annual rate (CAGR) of 28% over three years, including 36% growth in the latest year. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32,834 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | -9.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Starcine Pharmaceutical Private Limited, buy the company report.
Board of directors of Starcine Pharmaceutical Private Limited
Starcine Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagendra Ramachndrappa | Director | 20 Jan 2021 | 5 Years 9 Months | Current |
| Manjunath Narayana | Director | 27 Nov 2020 | 5 Years 10 Months | Current |
| Cheegatagere Ganga Reddy Lakshmana Reddy | Director | 27 Nov 2020 | 5 Years 10 Months | Current |
Peer comparison
Starcine Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Elvimed Pharma Private Limited | ₹32.25 Lakh (FY 2023) | Pune, Maharashtra, India | ||||
| Aurenyx Pharmatech Private Limited | ₹31.57 Lakh (FY 2025) | 29.0% | Shirur, Maharashtra, India | |||
| Aerolite Pharmaceuticals Private Limited | ₹31.53 Lakh (FY 2025) | 17.0% | Pune, Maharashtra, India | |||
| Clinimed Allergy Solutions Private Limited | ₹31.5 Lakh (FY 2024) | 343.0% | Bangalore, Karnataka, India | |||
| Raizel Biotech Private Limited | ₹31.47 Lakh (FY 2025) | 920.0% | Chandigarh, India | |||
| Starcine Pharmaceutical Private Limitedthis company | ₹31.17 Lakh (FY 2025) | -₹3.03 Lakh | -9.7% | 36.0% | Bangalore, Karnataka, India | |
| Kindness Pharma Private Limited | ₹31.05 Lakh (FY 2025) | -3.0% | Udaipur, Rajasthan, India | |||
| Mclaren Labs Private Limited | ₹31.01 Lakh (FY 2025) | 19.0% | Delhi, India | |||
| Mirana Industries Private Limited | ₹30.17 Lakh (FY 2024) | 12.0% | Bengaluru, Karnataka, India | |||
| Presinus Pharmaceuticals Private Limited | ₹29.88 Lakh (FY 2025) | -24.0% | Nagpur, Maharashtra, India | |||
| Gomatha Ayur Private Limited | ₹29.88 Lakh (FY 2025) | -35.0% | Doddaballapura, Karnataka, India |
To see the full peer comparison of Starcine Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Starcine Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Starcine Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Starcine Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Starcine Pharmaceutical Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Yuvaraju Gojalla ceased to be Director on 30 Apr 2025.
AGM
Starcine Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Yuvaraju Gojalla ceased to be Director.
Filing
Starcine Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Nagendra Ramachndrappa ceased to be Director.
Appointed
Nagendra Ramachndrappa was appointed as Director.
Appointed
Cheegatagere Ganga Reddy Lakshmana Reddy was appointed as Director.
Appointed
Manjunath Narayana was appointed as Director.
Incorporation
27 Nov 2020
Starcine Pharmaceutical Private Limited was registered on 27 Nov 2020 with Roc Bangalore & aged 5 years 10 months as per MCA records.
Frequently asked questions
Starcine Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 November 2020 (6+ years old) and is registered under CIN U24290KA2020PTC141585.
Starcine Pharmaceutical has 3 current directors:
- Nagendra Ramachndrappa - Director
- Manjunath Narayana - Director
- Cheegatagere Ganga Reddy Lakshmana Reddy - Director
The latest financial statements of Starcine Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Starcine Pharmaceutical is U24290KA2020PTC141585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Starcine Pharmaceutical was incorporated on 27 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Starcine Pharmaceutical by revenue are Elvimed Pharma Private Limited, Aurenyx Pharmatech Private Limited, Aerolite Pharmaceuticals Private Limited, Clinimed Allergy Solutions Private Limited, Raizel Biotech Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Yuvaraju Gojalla ceased to be Director on 30 Apr 2025. Nagendra Ramachndrappa ceased to be Director on 30 Dec 2021. Nagendra Ramachndrappa was appointed as Director on 20 Jan 2021. Starcine Pharmaceutical has 5 board changes on record in total.
Yes, Starcine Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0041706).
The registered office of Starcine Pharmaceutical is at No 52 Cellar Shivasharada Complex Annapoorneshwari Complex Srigandhada Ka, Val, Bangalore, Karnataka, India – 560091.
Starcine Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Starcine Pharmaceutical can be reached at its registered office: No 52 Cellar Shivasharada Complex Annapoorneshwari Complex Srigandhada Ka, Val, Bangalore, Karnataka, India – 560091.